1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Management of Hepatitis C: 2002 (Day 1)\n"}],["$","meta","1",{"name":"description","content":"NIH Consensus Development Conference\n

\nThe hepatitis C virus (HCV) is the leading cause of liver disease in the United States and certainly the most common cause of cirrhosis and hepatocellular carcinoma; it is also the most common reason for liver transplantation. Almost 4 million people in this country are believed to be infected with this virus. Following its identification first in 1974 as non-A, non-B hepatitis, shown later to be predominantly a consequence of HCV infection, much was learned about the virus and the disease it causes. Chief among these was the issue of how to manage and treat the liver disease. \n

\nFor more information, visit
\nNIH Consensus Development Conference
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Management of Hepatitis C: 2002 (Day 1)\n"}],["$","meta","4",{"property":"og:description","content":"NIH Consensus Development Conference\n

\nThe hepatitis C virus (HCV) is the leading cause of liver disease in the United States and certainly the most common cause of cirrhosis and hepatocellular carcinoma; it is also the most common reason for liver transplantation. Almost 4 million people in this country are believed to be infected with this virus. Following its identification first in 1974 as non-A, non-B hepatitis, shown later to be predominantly a consequence of HCV infection, much was learned about the virus and the disease it causes. Chief among these was the issue of how to manage and treat the liver disease. \n

\nFor more information, visit
\nNIH Consensus Development Conference
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/96b3da14-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/aa60a7a6-a4dc-463a-b181-5648d08c6ab7.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Management of Hepatitis C: 2002 (Day 1)\n"}],["$","meta","11",{"name":"twitter:description","content":"NIH Consensus Development Conference\n

\nThe hepatitis C virus (HCV) is the leading cause of liver disease in the United States and certainly the most common cause of cirrhosis and hepatocellular carcinoma; it is also the most common reason for liver transplantation. Almost 4 million people in this country are believed to be infected with this virus. Following its identification first in 1974 as non-A, non-B hepatitis, shown later to be predominantly a consequence of HCV infection, much was learned about the virus and the disease it causes. Chief among these was the issue of how to manage and treat the liver disease. \n

\nFor more information, visit
\nNIH Consensus Development Conference
"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/aa60a7a6-a4dc-463a-b181-5648d08c6ab7.jpg"}],"$L22","$L23"],"error":null,"digest":"$undefined"}